Verition Fund Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-122,282
| Closed | -$194K | – | 3128 |
|
|
2025
Q1 | $194K | Sell |
122,282
-1,094,812
| -90% | -$1.74M | ﹤0.01% | 2396 |
|
|
2024
Q4 | $3.69M | Sell |
1,217,094
-287,226
| -19% | -$870K | 0.01% | 864 |
|
|
2024
Q3 | $5.54M | Buy |
1,504,320
+951,500
| +172% | +$3.5M | 0.03% | 608 |
|
|
2024
Q2 | $2.26M | Sell |
552,820
-602,416
| -52% | -$2.46M | 0.01% | 828 |
|
|
2024
Q1 | $18.2M | Buy |
1,155,236
+810,619
| +235% | +$12.8M | 0.12% | 114 |
|
|
2023
Q4 | $5.22M | Sell |
344,617
-192,742
| -36% | -$2.92M | 0.04% | 390 |
|
|
2023
Q3 | $10.8M | Buy |
537,359
+30,339
| +6% | +$609K | 0.13% | 174 |
|
|
2023
Q2 | $14.3M | Buy |
507,020
+116,438
| +30% | +$3.28M | 0.19% | 113 |
|
|
2023
Q1 | $6.72M | Buy |
+390,582
| New | +$6.72M | 0.09% | 254 |
|
|
2022
Q2 | – | Sell |
-40,714
| Closed | -$1.88M | – | 2441 |
|
|
2022
Q1 | $1.88M | Buy |
+40,714
| New | +$1.88M | 0.02% | 688 |
|
|
2021
Q2 | – | Sell |
-64,718
| Closed | -$2.81M | – | 2038 |
|
|
2021
Q1 | $2.81M | Buy |
64,718
+53,148
| +459% | +$2.31M | 0.03% | 261 |
|
|
2020
Q4 | $601K | Sell |
11,570
-7,830
| -40% | -$407K | 0.01% | 517 |
|
|
2020
Q3 | $634K | Buy |
+19,400
| New | +$634K | 0.01% | 420 |
|